For over 75 years, Doheny Eye Institute has been at the forefront of groundbreaking vision research, leading to breakthrough treatments and medical advancements in the Greater Los Angeles area and the world. Over the last 30 years, Marissa Goldberg, CEO, has been an indelible part of the mark Doheny continues to make on vision care throughout the Los Angeles area.
In her role, Goldberg is committed to ensuring everyone at Doheny upholds its mission
to further the conservation, improvement and restoration of human eyesight. During her three-decade career at Doheny, she has held a variety of roles including human resources director, quality improvement coach, CAO, vice president, COO, and executive director before being named CEO.
Through Goldberg’s business guidance, she and the Doheny Board of Directors worked tirelessly to forge a new, powerful alliance and ensure a smooth union between Doheny and UCLA. Doheny’s affiliation with UCLA Stein Eye Institute combines the strength, reputation and distinction of two of the nation’s top eye institutions.
Today, Doheny Eye Institute continues to attract top vision scientists. With Goldberg’s guidance and support, along with her commitment to securing funding for the important work of Doheny, the incredible team of scientists continue to make transformative discoveries. In just the last few years alone, Doheny scientists have developed novel eye imaging equipment, computer-based retinal image analysis, identified retinal biomarkers for Alzheimer’s Disease and developed multiple animal models of ocular disease – with groundbreaking research continuing every day.
In the past 10 years under Goldberg’s leadership, Doheny’s assets have more than doubled – strengthening its reputation as a leader in ophthalmology and vision research. Doheny has ranked in the Top Ten Best Ophthalmology.
Hospitals by U.S. News and World Report each year since rankings began in 1993, and in the Top 5 since Doheny’s affiliation with UCLA Stein Eye Institute in 2013. Additionally, Doheny has been ranked in the Top 10 by Ophthalmology Times since rankings began in 1996.
A lifelong resident of the Los Angeles area, Goldberg is committed to supporting the com- munity and and supporting innovative research to find treatments and cures for debilitating eye diseases that affect people worldwide. She is also deeply focused on strengthening Doheny’s expertise and reputation locally and nationally, and advancing its fundraising efforts to support its groundbreaking vision research.
In November 2021, Doheny moved into its new main campus in Pasadena. This transition fulfills a strategic vision to bring together physicians, researchers, administrative and technical staff under one roof to further accelerate scientific discovery that improves lives. Doheny purchased the building, which had previously been an office building, as shell space and built out state of the art research space, laboratories, and support facilities.
Goldberg strongly believes Doheny Eye Institute is in a position to be the best vision research institute in the world because of its unflagging commitment to advance vision science and education, its exceptional scientists and staff, as well as the many supporters, stakeholders, and friends who make Doheny’s mission possible.
The entire team at Doheny is eagerly looking forward to a bright future in Pasadena.
More information about the impressive impact of Doheny on vision care, along with the vision scientists contributing to new findings every day, can be found at Doheny.org.
